Large Bipartisan Group Of Lawmakers Defends Protected Drug Classes

By John Wilkerson / March 14, 2019 at 5:33 PM
A bipartisan group of more than 70 House lawmakers wants CMS to withdraw a proposal to weaken coverage protections in six classes of drugs, according to a March 13 letter to HHS Secretary Alex Azar . Patient and provider groups have been highly critical of the Trump administration’s proposal to let insurers use step therapy and prior authorization for drugs in those drug classes, and now CMS is feeling the pressure from Congress. The letter focuses on HIV drugs, which...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.